# HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)

> **NCT02087384** · PHASE4 · COMPLETED · sponsor: **Prof. Jan Prins** · enrollment: 126 (actual)

## Conditions studied

- AIN
- HIV

## Interventions

- **BIOLOGICAL:** Gardasil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02087384
- **Lead sponsor:** Prof. Jan Prins
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2018-07
- **Final completion:** 2019-02
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02087384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02087384, "HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02087384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*